US tariffs on Indian medical supplies are driving healthcare costs higher, warns Bionova Group’s Suddhir Jain. “Tariffs have pushed medical device prices up by as much as 25%, contributing to a significant rise in overall healthcare expenses, adding billions more to the US medical cost burden,” he said, urging strategic industry action to counter the impact.